Sangamo Therapeutics
SGMO
#8726
Rank
S$0.21 B
Marketcap
S$0.64
Share price
-6.45%
Change (1 day)
-76.16%
Change (1 year)

Market capitalization of Sangamo Therapeutics (SGMO)

Market cap: S$0.21 Billion

As of December 2025 Sangamo Therapeutics has a market cap of S$0.21 Billion. This makes Sangamo Therapeutics the world's 8726th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sangamo Therapeutics from 2000 to 2025

End of year Market Cap

Year Marketcap Change
2025S$0.21 B-70.22%
2024S$0.72 B470.55%
2023S$0.12 B-81.55%
2022S$0.68 B-53.3%
2021S$1.47 B-49.42%
2020S$2.91 B123.13%
2019S$1.30 B-18.34%
2018S$1.60 B-13.56%
2017S$1.85 B494.69%
2016S$0.31 B-65.69%
2015S$0.90 B-34.54%
2014S$1.38 B26.71%
2013S$1.09 B180.9%
2012S$0.38 B102.06%
2011S$0.19 B-50.28%
2010S$0.38 B3.79%
2009S$0.37 B83.36%
2008S$0.20 B-73%
2007S$0.75 B112.98%
2006S$0.35 B72.9%
2005S$0.20 B-17.07%
2004S$0.24 B6.66%
2003S$0.23 B79.48%
2002S$0.12 B-69.47%
2001S$0.42 B-43.45%
2000S$0.74 B

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of Sangamo Therapeutics was reported to be:

S$0.21 Billion
by Nasdaq info icon info icon
S$0.21 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
S$194.91 B 90,037.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$78.43 B 36,170.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$230.20 B 106,355.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$34.46 B 15,839.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
S$21.14 B 9,679.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$630.46 B 291,453.85%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$13.29 B 6,047.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$322.78 B 149,167.40%๐Ÿ‡บ๐Ÿ‡ธ USA